Ausgabe 4/2017
Inhalt (14 Artikel)
Clinical Trials (J Butler, Section Editor)
Impact of Site Selection and Study Conduct on Outcomes in Global Clinical Trials
Chaudhry M. S. Sarwar, Muthiah Vaduganathan, Javed Butler
Clinical Trials (J Butler, Section Editor)
Novel Endpoints for Heart Failure Clinical Trials
Carine E. Hamo, Mihai Gheorghiade, Javed Butler
Clinical Trials (J Butler, Section Editor)
Designing Future Clinical Trials in Heart Failure With Preserved Ejection Fraction: Lessons From TOPCAT
Ravi B. Patel, Sanjiv J. Shah, Gregg C. Fonarow, Javed Butler, Muthiah Vaduganathan
Comorbidities of Heart Failure (C Angermann & F Edelmann, Section Editors)
Towards Holistic Heart Failure Management—How to Tackle the Iron Deficiency Epidemic?
Lucas N. L. Van Aelst, Dominiek Mazure, Alain Cohen-Solal
Open Access
Comorbidities of Heart Failure (C Angermann & F Edelmann, Section Editors)
From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities
Navin Suthahar, Wouter C. Meijers, Herman H.W. Silljé, Rudolf A. de Boer
Open Access
Comorbidities of Heart Failure (C Angermann and F Edelmann, Section Editors)
Inflammation – Cause or Consequence of Heart Failure or Both?
Sophie Van Linthout, Carsten Tschöpe
Pathophysiology of Myocardial Failure (Inder Anand and Maria Patarroyo-Aponte, Section Editors)
Treatment of Hyperkalemia in Heart Failure
Ersilia M. DeFilippis, Akshay S. Desai
Pharmacologic Therapy (W H W Tang, Section Editor)
Role of SGLT2 Inhibitors in Patients with Diabetes Mellitus and Heart Failure
Frederik H. Verbrugge
Biomarkers of Heart Failure (W.H.W. Tang and J.L. Grodin, Section Editors)
Biomarkers in Sleep Apnea and Heart Failure
Ying Y. Zhao, Reena Mehra
Biomarkers of Heart Failure (W.H.W. Tang and J.L. Grodin, Section Editors)
Novel Biomarkers of Subclinical Cardiac Dysfunction in the General Population
Kamal Shemisa, Anish Bhatt, Daniel Cheeran, Ian J. Neeland
Biomarkers of Heart Failure (W.H.W. Tang and J.L. Grodin, Section Editors)
The Basic Metabolic Profile in Heart Failure—Marker and Modifier
Ahmed Elfar, Kamalanathan K. Sambandam
Pharmacologic Therapy (W H W Tang, Section Editor)
Therapeutic Strategies Targeting Inherited Cardiomyopathies
Kenneth Varian, W. H. Wilson Tang
Pathophysiology of Myocardial Failure (Inder Anand and Maria Patarroyo-Aponte, Section Editors)
SGLT-2 Inhibitors in Heart Failure: Implications for the Kidneys
Frederik H. Verbrugge, Pieter Martens, Wilfried Mullens
Experimental Therapeutics (L.S. Maier, Section Editor)
Targeting Mitochondrial Calcium Handling and Reactive Oxygen Species in Heart Failure
Alexander Dietl, Christoph Maack